Regulatory function of a novel population of mouse autoantigen-specific Foxp3- regulatory T cells depends on IFN-γ, NO, and contact with target cells

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Chen, Cyndi ^a   Liu, Chih Pin ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; NITRIC OXIDE; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HLA ANTIGEN CLASS 2; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CONTACT; CONTROLLED STUDY; DOWNSTREAM PROCESSING; FEMALE; IMMUNOREGULATION; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; TARGET CELL; ADOPTIVE TRANSFER; ANIMAL; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NONOBESE DIABETIC MOUSE; SPLEEN;

ANIMALIA; MUS;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON-GAMMA; INTERLEUKIN-10; MICE; MICE, INBRED NOD; NITRIC OXIDE; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 70849083675     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007863     Document Type: Article

References (43)

1. Sakaguchi S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
2. Shevach EM (2004) Regulatory/suppressor T cells in health and disease. Arthritis Rheum 50: 2721-2724.
3. Ziegler SF (2006) FOXP3: of mice and men. Annu Rev Immunol 24: 209-226.
4. O'Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nature Medicine 10: 801-805.
5. Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R (2005) Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J Exp Med 201: 1333-1346.
6. You S, Belghith M, Cobbold S, Alyanakian MA, Gouarin C, et al. (2005) Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54: 1415-1422.
7. Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA (2005) Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in T1D. Diabetes 54: 1407-1414.
8. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM (2004) CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 199: 1467-1477.
9. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199: 1455-1465.
10. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352.
11. Piccirillo CA, Shevach EM (2004) Naturally-occurring CD4+CD25+ immuno-regulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 16: 81-88.
12. O'Garra A, Vieira PL, Vieira P, Goldfeld AE (2004) IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114: 1372-1378.
13. Maloy KJ, Powrie F (2001) Regulatory T cells in the control of immune pathology. Nat Immunol 2: 816-822.
14. Roncarolo MG, Levings MK (2000) The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 12: 676-683.
15. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
16. Chen C, Lee W-H, Yun P, Snow P, Liu C-P (2003) Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol 171: 733-744.
17. Chen C, Lee W-H, Zong LW, Liu C-P (2006) Regulatory T cells can mediate their function through the stimulation of antigen-presenting cells to produce immunosuppressive nitric oxide. J Immunol 176: 3449-3460.
18. You S, Chen C, Lee WH, Brusko T, Atkinson M, et al. (2004) Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. J Immunol 173: 6777-6785.
19. von Boehmer H (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6: 338-344.
20. + regulatory T cells. Int J Immunol 16: 1189-1201.
21. Hori S, Haury M, Coutinho A, Demengeot J (2002) Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 99: 8213-8218.
22. g7 tetramers. Proc Natl Acad Sci USA 97: 14596-14601.
23. You S, Chen C, Lee WH, Wu CH, Judkowski V, et al. (2003) Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides. J Immunol 170: 4011-4020.
24. Prochazka M, Serreze DV, Frankel WN, Leiter EH (1992) NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41: 98-106.
25. Serreze DV, Prochazka M, Reifsnyder PC, Bridgett MM, Leiter EH (1994) Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J Exp Med 180: 1553-1558.
26. Judkowski V, Pinilla C, Schroder K, Tucker L, Sarvetnick N, et al. (2001) Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 Nonobese diabetic mice. J Immunol 166: 908-917.
27. Chao CC, McDevitt HO (1997) Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice. Immunogenetics 46: 29-34.
28. Tarbell KV, Lee M, Ranheim E, Chao CC, Sanna M, et al. (2002) CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J Exp Med 196: 481-492.
29. Kim SK, Tarbell KV, Sanna M, Vadeboncoeur M, Warganich T, et al. (2004) Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells. Proc Natl Acad Sci USA 101: 14204-14209.
30. Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Chéramy M, et al. (2008) GAD treatment and insulin secretion in recent-onset T1D. N Engl J Med 359: 1909-1920.
31. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-795.
32. Schloot NC, Hanifi-Moghaddam P, Goebel C, Shatavi SV, Flohe S, et al. (2002) Serum IFN-g and IL-10 levels are associated with disease progression in non-obese diabetic mice. Diab/Metabol Res and Rev 18: 64-70.
33. Wang B, Andre I, Gonzalez A, Katz JD, Aguet M, et al. (1997) Interferon-g impacts a multiple points during the progression of autoimmune diabetes. Proc Natl Acad Sci USA 94: 13844-13849.
34. Steinman L (2001) Blockade of gamma interferon might be beneficial in MS. Mult Scler 7: 275-276.
35. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH (2003) Molecular mechanisms regulating Th1 immune responses. Ann Rev Immunol 21: 713-758.
36. Billiau A, Heremans H, Vermeire K, Matthys P (1998) Immunomodulatory properties of interferon-gamma. An update. Ann NY Acad Sci 856: 22-32.
37. Rosloniec EF, Latham K, Guedez YB (2002) Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity. Arthritis Res 4: 333-336.
38. Bending D, De La Peûa H, Veldhoen M, Phillips JM, Uyttenhove C, et al. (2009) Highly purified Th17 cells from BDC2.5 NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 119: 565-572.
39. Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 39: 216-224.
40. Dong C (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8: 337-348.
41. Huang FP, Niedbala W, Wei XQ, Xu D, Feng GJ, et al. (1998) Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthase by macrophages. Eur J Immunol 28: 4062-4070.
42. Mazzoni A, Bronte V, Visintin A, Spitze JH, Apolloni E, et al. (2002) Myeloid suppressor lines inhibits T cell responses by an NO-dependent mechanism. J Immunol 168: 689-695.
43. Van der Veen RC, Dietlin TA, Pen L, Gray JD (1999) Nitric oxide inhibits the proliferation of Th1 and 2 lymphocytes without reduction in cytokine secretion. Cell Immunol 193: 194-201.